Statins, structural analogs of HMG-CoA reductase inhibitors, have been instrumental towards attenuating cardiac hypertrophy, cardiomyocyte apoptosis, endothelial dysfunction and oxidative stress [307,308]. Here, HMGCR is linked to endothelial dysfunction.